YSP Southeast Asia Holding Bhd (7178) - Total Liabilities
Based on the latest financial reports, YSP Southeast Asia Holding Bhd (7178) has total liabilities worth RM123.18 Million MYR (≈ $30.93 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore YSP Southeast Asia Holding Bhd (7178) cash flow conversion to assess how effectively this company generates cash.
YSP Southeast Asia Holding Bhd - Total Liabilities Trend (2012–2025)
This chart illustrates how YSP Southeast Asia Holding Bhd's total liabilities have evolved over time, based on quarterly financial data. Check 7178 financial resilience to evaluate the company's liquid asset resilience ratio.
YSP Southeast Asia Holding Bhd Competitors by Total Liabilities
The table below lists competitors of YSP Southeast Asia Holding Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Exagen Inc
NASDAQ:XGN
|
USA | $44.69 Million |
|
Wellell Inc
TW:4106
|
Taiwan | NT$729.71 Million |
|
Shanghai Shibei Hi-Tech Co Ltd B
SHG:900902
|
China | $12.13 Billion |
|
Mukka Proteins Limited
NSE:MUKKA
|
India | Rs7.77 Billion |
|
MFC Asset Management Public Company Limited
BK:MFC
|
Thailand | ฿772.84 Million |
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
USA | $7.89 Million |
|
Aker Technology Co Ltd
TWO:6174
|
Taiwan | NT$319.96 Million |
|
C3 Metals Inc
V:CCCM
|
Canada | CA$1.11 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down YSP Southeast Asia Holding Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 7178 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.09 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how YSP Southeast Asia Holding Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for YSP Southeast Asia Holding Bhd (2012–2025)
The table below shows the annual total liabilities of YSP Southeast Asia Holding Bhd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | RM115.36 Million ≈ $28.96 Million |
-3.64% |
| 2024-12-31 | RM119.72 Million ≈ $30.06 Million |
-4.74% |
| 2023-12-31 | RM125.68 Million ≈ $31.55 Million |
+23.36% |
| 2022-12-31 | RM101.89 Million ≈ $25.58 Million |
+0.63% |
| 2021-12-31 | RM101.25 Million ≈ $25.42 Million |
-4.62% |
| 2020-12-31 | RM106.15 Million ≈ $26.65 Million |
+2.51% |
| 2019-12-31 | RM103.55 Million ≈ $26.00 Million |
+6.36% |
| 2018-12-31 | RM97.36 Million ≈ $24.44 Million |
+20.95% |
| 2017-12-31 | RM80.49 Million ≈ $20.21 Million |
+20.70% |
| 2016-12-31 | RM66.69 Million ≈ $16.74 Million |
+9.33% |
| 2015-12-31 | RM61.00 Million ≈ $15.32 Million |
+3.39% |
| 2014-12-31 | RM59.00 Million ≈ $14.81 Million |
-14.49% |
| 2013-12-31 | RM69.00 Million ≈ $17.32 Million |
-5.48% |
| 2012-12-31 | RM73.00 Million ≈ $18.33 Million |
-- |
About YSP Southeast Asia Holding Bhd
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, an… Read more